Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China flag China · Delayed Price · Currency is CNY
6.77
-0.21 (-3.01%)
Apr 3, 2026, 3:00 PM CST

SHA:600223 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-2,9481,7344,3185,139
Cash & Short-Term Investments
2,7512,9481,7344,3185,139
Cash Growth
-6.67%70.04%-59.85%-15.97%1.27%
Accounts Receivable
-511.85599.06428.31306.23
Other Receivables
-21.223,0521,3071,226
Receivables
-533.073,6521,7401,532
Inventory
-558.71525.4446,04748,204
Prepaid Expenses
---491.91608.15
Other Current Assets
-10473.853,0323,187
Total Current Assets
-4,1445,98455,62958,670
Property, Plant & Equipment
-1,1921,2031,3821,345
Long-Term Investments
-168.53191.76926.97874.1
Goodwill
-153.74153.74155.59160.33
Other Intangible Assets
-163.22148.7196.5210.1
Long-Term Deferred Tax Assets
-29.8223.66105.04101.25
Long-Term Deferred Charges
-91.1153.9652.3440.51
Other Long-Term Assets
-58.7358.2626.2213.92
Total Assets
-6,0007,81858,47461,415
Accounts Payable
-413.35452.989,2668,694
Accrued Expenses
-136.53127.321,003948.47
Short-Term Debt
-212.12705.222,2703,219
Current Portion of Long-Term Debt
-12.51790.343,2222,307
Current Portion of Leases
-9.218.165.681.99
Current Income Taxes Payable
-16.359.5226.5918.81
Current Unearned Revenue
-122.97108.4417,86921,686
Other Current Liabilities
-183.3199.7816,94414,217
Total Current Liabilities
-1,1062,40250,60651,093
Long-Term Debt
-44.55665.042,2153,751
Long-Term Leases
-7.5312.9821.377.69
Long-Term Unearned Revenue
-51.2355.1855.6359.17
Long-Term Deferred Tax Liabilities
-2.312.738.555.24
Total Liabilities
-1,2123,13852,90754,916
Common Stock
-1,0171,0171,0171,009
Additional Paid-In Capital
-612.86612.51617.8616.38
Retained Earnings
-2,4752,3852,0822,202
Comprehensive Income & Other
--0.290.33900
Total Common Equity
4,1874,1054,0153,7174,727
Minority Interest
-683.47665.371,8501,773
Shareholders' Equity
4,8894,7884,6805,5676,500
Total Liabilities & Equity
-6,0007,81858,47461,415
Total Debt
200.07285.922,1827,7359,287
Net Cash (Debt)
2,5512,662-448.16-3,417-4,149
Net Cash Growth
-4.16%----
Net Cash Per Share
2.452.62-0.44-3.01-4.01
Filing Date Shares Outstanding
1,1351,0171,0171,0171,009
Total Common Shares Outstanding
1,1351,0171,0171,0171,009
Working Capital
-3,0373,5835,0237,577
Book Value Per Share
4.124.043.953.663.79
Tangible Book Value
3,8693,7883,7123,3654,357
Tangible Book Value Per Share
3.813.733.653.313.43
Buildings
-1,0459171,3121,294
Machinery
-681.06620.81604.52551.66
Construction In Progress
-16.12131.3672.9540.99
Source: S&P Global Market Intelligence. Standard template. Financial Sources.